IDH1 and central nervous system cancer: This is in line with a previous report which demonstrated that xenografting of cultured IDH1 mutant glioma cells hardly results in in vivo tumor growth [38] and is in sharp contrast with our experience with orthotopic xenografting of IDH1wt gliomas in which success rates approach 100%.